It stimulates the pituitary gland to produce and release human growth hormone (HGH), which is essential for growth, metabolism, and cell repair
The Glucagon Paradox in Next-Generation Incretin Therapy: How GLP-1, GIP, and Glucagon Receptor Co-Agonism May Amplify Weight Loss Despite Glucagons Hyperglycemic Biology Abstract The development of dual and triple incretin-based receptor agonists represents a major advance in the pharmacologic treatment of obesity, type 2 diabetes, and related cardiometabolic disease
No GLP-1 patch brand has published such a trial
We hold valid ISO9001:2015, HACCP and GMP production system certificates
Bock FJ, Tait S
Derry PJ, Hegde ML, Jackson GR, Kayed R, Tour JM, Tsai AL